Leeds Institute of Molecular Medicine, St James's University Hospital
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hull, Mark A
PLATINUM-CAN, NCT05534165: Tecovirimat in Non-hospitalized Patients With Monkeypox

Recruiting
3
120
Canada
Tecovirimat, TPOXX, Placebo
Marina Klein, McGill University Health Centre/Research Institute of the McGill University Health Centre, University Health Network, Toronto, Unity Health Toronto, University of British Columbia, CIHR Canadian HIV Trials Network
Monkeypox
06/24
03/25
EMT2, NCT03428477 / 2016-000628-24: EPA for Metastasis Trial 2

Active, not recruiting
3
418
Europe
Icosapent Ethyl, Vascepa, Placebo
Mark A Hull, PhD FRCP, Yorkshire Cancer Research, Amarin Pharma Inc.
Liver Metastasis, Colon Cancer
11/25
04/26
MPOCS, NCT06291259: Mpox Prospective Observational Cohort Study

Recruiting
N/A
250
Canada
Unity Health Toronto
Monkeypox
09/24
09/24
NCT04682665: Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

Recruiting
N/A
250
Europe
Icosapent Ethyl Oral Capsule, Placebo
University of Leeds, National Cancer Institute (NCI), Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard School of Public Health (HSPH), University of Bradford
Colon Cancer Liver Metastasis
07/24
07/25

Download Options